nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—CHRNA4—telencephalic ventricle—malignant glioma	0.0401	0.107	CbGeAlD
Varenicline—CHRNA6—brainstem—malignant glioma	0.0302	0.0804	CbGeAlD
Varenicline—CHRNA6—telencephalon—malignant glioma	0.0268	0.0713	CbGeAlD
Varenicline—CHRNA6—midbrain—malignant glioma	0.0193	0.0512	CbGeAlD
Varenicline—Facial paralysis—Carmustine—malignant glioma	0.0188	0.0302	CcSEcCtD
Varenicline—Sensory disturbance—Temozolomide—malignant glioma	0.0186	0.0299	CcSEcCtD
Varenicline—CHRNA3—retina—malignant glioma	0.0163	0.0432	CbGeAlD
Varenicline—Abnormal behaviour—Temozolomide—malignant glioma	0.0155	0.0249	CcSEcCtD
Varenicline—CHRNB2—telencephalon—malignant glioma	0.0154	0.041	CbGeAlD
Varenicline—CHRNA6—central nervous system—malignant glioma	0.0153	0.0405	CbGeAlD
Varenicline—CHRNA6—cerebellum—malignant glioma	0.0149	0.0396	CbGeAlD
Varenicline—VIIth nerve paralysis—Carmustine—malignant glioma	0.0146	0.0234	CcSEcCtD
Varenicline—CHRNB2—medulla oblongata—malignant glioma	0.0121	0.0322	CbGeAlD
Varenicline—CHRNA6—brain—malignant glioma	0.0121	0.0322	CbGeAlD
Varenicline—CHRFAM7A—telencephalon—malignant glioma	0.0121	0.0321	CbGeAlD
Varenicline—Transient ischaemic attack—Temozolomide—malignant glioma	0.0115	0.0184	CcSEcCtD
Varenicline—CHRNB2—midbrain—malignant glioma	0.0111	0.0294	CbGeAlD
Varenicline—CHRNA4—brainstem—malignant glioma	0.0109	0.0288	CbGeAlD
Varenicline—CHRNB2—spinal cord—malignant glioma	0.0108	0.0287	CbGeAlD
Varenicline—CHRNA7—retina—malignant glioma	0.0106	0.0282	CbGeAlD
Varenicline—CHRNA7—telencephalon—malignant glioma	0.00976	0.026	CbGeAlD
Varenicline—CHRNA4—telencephalon—malignant glioma	0.00963	0.0256	CbGeAlD
Varenicline—Cyst—Carmustine—malignant glioma	0.00895	0.0143	CcSEcCtD
Varenicline—Parosmia—Temozolomide—malignant glioma	0.00891	0.0143	CcSEcCtD
Varenicline—Paranoia—Carmustine—malignant glioma	0.00878	0.0141	CcSEcCtD
Varenicline—CHRNB2—central nervous system—malignant glioma	0.00876	0.0233	CbGeAlD
Varenicline—CHRNB2—cerebellum—malignant glioma	0.00856	0.0228	CbGeAlD
Varenicline—CHRNA3—central nervous system—malignant glioma	0.0085	0.0226	CbGeAlD
Varenicline—Thrombosis—Carmustine—malignant glioma	0.00845	0.0135	CcSEcCtD
Varenicline—CHRNA3—cerebellum—malignant glioma	0.0083	0.0221	CbGeAlD
Varenicline—Scotoma—Carmustine—malignant glioma	0.00788	0.0126	CcSEcCtD
Varenicline—Menorrhagia—Temozolomide—malignant glioma	0.00781	0.0125	CcSEcCtD
Varenicline—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00768	0.0123	CcSEcCtD
Varenicline—Scotoma—Temozolomide—malignant glioma	0.00761	0.0122	CcSEcCtD
Varenicline—Endocrine disorder—Temozolomide—malignant glioma	0.00697	0.0112	CcSEcCtD
Varenicline—CHRNB2—brain—malignant glioma	0.00696	0.0185	CbGeAlD
Varenicline—CHRNA4—midbrain—malignant glioma	0.00692	0.0184	CbGeAlD
Varenicline—CHRFAM7A—central nervous system—malignant glioma	0.00687	0.0183	CbGeAlD
Varenicline—Accidental injury—Carmustine—malignant glioma	0.00676	0.0108	CcSEcCtD
Varenicline—CHRNA4—spinal cord—malignant glioma	0.00675	0.0179	CbGeAlD
Varenicline—CHRNA3—brain—malignant glioma	0.00675	0.0179	CbGeAlD
Varenicline—Disturbance in attention—Temozolomide—malignant glioma	0.00667	0.0107	CcSEcCtD
Varenicline—Thinking abnormal—Carmustine—malignant glioma	0.00653	0.0105	CcSEcCtD
Varenicline—Viral infection—Temozolomide—malignant glioma	0.0064	0.0103	CcSEcCtD
Varenicline—Leukocytosis—Carmustine—malignant glioma	0.00637	0.0102	CcSEcCtD
Varenicline—Coordination abnormal—Carmustine—malignant glioma	0.00609	0.00977	CcSEcCtD
Varenicline—Pulmonary embolism—Carmustine—malignant glioma	0.00598	0.00959	CcSEcCtD
Varenicline—Coordination abnormal—Temozolomide—malignant glioma	0.00589	0.00944	CcSEcCtD
Varenicline—Musculoskeletal pain—Temozolomide—malignant glioma	0.00585	0.00938	CcSEcCtD
Varenicline—Pulmonary embolism—Temozolomide—malignant glioma	0.00578	0.00927	CcSEcCtD
Varenicline—Influenza like illness—Temozolomide—malignant glioma	0.00561	0.009	CcSEcCtD
Varenicline—CHRNA7—central nervous system—malignant glioma	0.00555	0.0148	CbGeAlD
Varenicline—CHRNA4—central nervous system—malignant glioma	0.00548	0.0146	CbGeAlD
Varenicline—CHRFAM7A—brain—malignant glioma	0.00546	0.0145	CbGeAlD
Varenicline—CHRNA4—cerebellum—malignant glioma	0.00535	0.0142	CbGeAlD
Varenicline—Dry eye—Temozolomide—malignant glioma	0.00534	0.00856	CcSEcCtD
Varenicline—Mental disability—Carmustine—malignant glioma	0.00519	0.00832	CcSEcCtD
Varenicline—Mental disability—Temozolomide—malignant glioma	0.00502	0.00804	CcSEcCtD
Varenicline—Diabetes mellitus—Carmustine—malignant glioma	0.00499	0.008	CcSEcCtD
Varenicline—Eye pain—Carmustine—malignant glioma	0.00481	0.00771	CcSEcCtD
Varenicline—Injury—Carmustine—malignant glioma	0.00472	0.00757	CcSEcCtD
Varenicline—Deafness—Temozolomide—malignant glioma	0.00469	0.00752	CcSEcCtD
Varenicline—Eye pain—Temozolomide—malignant glioma	0.00465	0.00745	CcSEcCtD
Varenicline—Amnesia—Carmustine—malignant glioma	0.00462	0.00741	CcSEcCtD
Varenicline—Hot flush—Temozolomide—malignant glioma	0.00449	0.00719	CcSEcCtD
Varenicline—Amnesia—Temozolomide—malignant glioma	0.00447	0.00716	CcSEcCtD
Varenicline—Menopausal symptoms—Temozolomide—malignant glioma	0.00445	0.00713	CcSEcCtD
Varenicline—Thirst—Temozolomide—malignant glioma	0.00441	0.00707	CcSEcCtD
Varenicline—CHRNA7—brain—malignant glioma	0.00441	0.0117	CbGeAlD
Varenicline—CHRNA4—brain—malignant glioma	0.00435	0.0116	CbGeAlD
Varenicline—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00434	0.00696	CcSEcCtD
Varenicline—Affect lability—Temozolomide—malignant glioma	0.00413	0.00662	CcSEcCtD
Varenicline—Liver function test abnormal—Carmustine—malignant glioma	0.00401	0.00643	CcSEcCtD
Varenicline—Mood swings—Temozolomide—malignant glioma	0.00398	0.00637	CcSEcCtD
Varenicline—Hypokalaemia—Carmustine—malignant glioma	0.00395	0.00634	CcSEcCtD
Varenicline—Dry skin—Temozolomide—malignant glioma	0.00385	0.00617	CcSEcCtD
Varenicline—Hypokalaemia—Temozolomide—malignant glioma	0.00382	0.00612	CcSEcCtD
Varenicline—Breast disorder—Temozolomide—malignant glioma	0.00379	0.00608	CcSEcCtD
Varenicline—Dysphagia—Carmustine—malignant glioma	0.00375	0.00602	CcSEcCtD
Varenicline—Abdominal distension—Temozolomide—malignant glioma	0.00365	0.00585	CcSEcCtD
Varenicline—Dysphagia—Temozolomide—malignant glioma	0.00363	0.00581	CcSEcCtD
Varenicline—Bronchitis—Temozolomide—malignant glioma	0.00349	0.00559	CcSEcCtD
Varenicline—Hyperglycaemia—Carmustine—malignant glioma	0.00339	0.00543	CcSEcCtD
Varenicline—Pollakiuria—Temozolomide—malignant glioma	0.00335	0.00537	CcSEcCtD
Varenicline—Erectile dysfunction—Temozolomide—malignant glioma	0.00334	0.00536	CcSEcCtD
Varenicline—Depression—Carmustine—malignant glioma	0.00334	0.00535	CcSEcCtD
Varenicline—Photosensitivity reaction—Temozolomide—malignant glioma	0.00331	0.00531	CcSEcCtD
Varenicline—Weight increased—Temozolomide—malignant glioma	0.0033	0.00529	CcSEcCtD
Varenicline—Hyperglycaemia—Temozolomide—malignant glioma	0.00327	0.00525	CcSEcCtD
Varenicline—Stomatitis—Carmustine—malignant glioma	0.00326	0.00523	CcSEcCtD
Varenicline—Infestation NOS—Temozolomide—malignant glioma	0.00323	0.00518	CcSEcCtD
Varenicline—Infestation—Temozolomide—malignant glioma	0.00323	0.00518	CcSEcCtD
Varenicline—Depression—Temozolomide—malignant glioma	0.00322	0.00517	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00321	0.00514	CcSEcCtD
Varenicline—Stomatitis—Temozolomide—malignant glioma	0.00315	0.00505	CcSEcCtD
Varenicline—Hepatobiliary disease—Temozolomide—malignant glioma	0.00306	0.0049	CcSEcCtD
Varenicline—Sinusitis—Temozolomide—malignant glioma	0.00303	0.00486	CcSEcCtD
Varenicline—Hallucination—Carmustine—malignant glioma	0.00299	0.00479	CcSEcCtD
Varenicline—Hypoaesthesia—Carmustine—malignant glioma	0.00299	0.00479	CcSEcCtD
Varenicline—Oedema peripheral—Carmustine—malignant glioma	0.00296	0.00474	CcSEcCtD
Varenicline—Connective tissue disorder—Carmustine—malignant glioma	0.00295	0.00473	CcSEcCtD
Varenicline—Visual impairment—Carmustine—malignant glioma	0.0029	0.00464	CcSEcCtD
Varenicline—Hypoaesthesia—Temozolomide—malignant glioma	0.00289	0.00463	CcSEcCtD
Varenicline—Hallucination—Temozolomide—malignant glioma	0.00289	0.00463	CcSEcCtD
Varenicline—Urinary tract disorder—Temozolomide—malignant glioma	0.00287	0.0046	CcSEcCtD
Varenicline—Oedema peripheral—Temozolomide—malignant glioma	0.00286	0.00458	CcSEcCtD
Varenicline—Connective tissue disorder—Temozolomide—malignant glioma	0.00285	0.00457	CcSEcCtD
Varenicline—Urethral disorder—Temozolomide—malignant glioma	0.00285	0.00456	CcSEcCtD
Varenicline—Eye disorder—Carmustine—malignant glioma	0.00281	0.0045	CcSEcCtD
Varenicline—Visual impairment—Temozolomide—malignant glioma	0.0028	0.00449	CcSEcCtD
Varenicline—Erythema multiforme—Temozolomide—malignant glioma	0.00274	0.0044	CcSEcCtD
Varenicline—Eye disorder—Temozolomide—malignant glioma	0.00271	0.00435	CcSEcCtD
Varenicline—Tinnitus—Temozolomide—malignant glioma	0.00271	0.00434	CcSEcCtD
Varenicline—Cardiac disorder—Temozolomide—malignant glioma	0.00269	0.00432	CcSEcCtD
Varenicline—Arrhythmia—Carmustine—malignant glioma	0.00268	0.0043	CcSEcCtD
Varenicline—Angiopathy—Temozolomide—malignant glioma	0.00263	0.00422	CcSEcCtD
Varenicline—Mental disorder—Carmustine—malignant glioma	0.00263	0.00422	CcSEcCtD
Varenicline—Immune system disorder—Temozolomide—malignant glioma	0.00262	0.0042	CcSEcCtD
Varenicline—Mediastinal disorder—Temozolomide—malignant glioma	0.00262	0.00419	CcSEcCtD
Varenicline—Erythema—Carmustine—malignant glioma	0.00262	0.00419	CcSEcCtD
Varenicline—Malnutrition—Carmustine—malignant glioma	0.00262	0.00419	CcSEcCtD
Varenicline—Chills—Temozolomide—malignant glioma	0.0026	0.00418	CcSEcCtD
Varenicline—Mental disorder—Temozolomide—malignant glioma	0.00254	0.00408	CcSEcCtD
Varenicline—Back pain—Carmustine—malignant glioma	0.00253	0.00406	CcSEcCtD
Varenicline—Erythema—Temozolomide—malignant glioma	0.00253	0.00405	CcSEcCtD
Varenicline—Malnutrition—Temozolomide—malignant glioma	0.00253	0.00405	CcSEcCtD
Varenicline—Dysgeusia—Temozolomide—malignant glioma	0.00247	0.00397	CcSEcCtD
Varenicline—Vision blurred—Carmustine—malignant glioma	0.00246	0.00395	CcSEcCtD
Varenicline—Tremor—Carmustine—malignant glioma	0.00245	0.00393	CcSEcCtD
Varenicline—Back pain—Temozolomide—malignant glioma	0.00244	0.00392	CcSEcCtD
Varenicline—Anaemia—Carmustine—malignant glioma	0.00242	0.00387	CcSEcCtD
Varenicline—Agitation—Carmustine—malignant glioma	0.0024	0.00385	CcSEcCtD
Varenicline—Vision blurred—Temozolomide—malignant glioma	0.00238	0.00382	CcSEcCtD
Varenicline—Tremor—Temozolomide—malignant glioma	0.00237	0.0038	CcSEcCtD
Varenicline—Ill-defined disorder—Temozolomide—malignant glioma	0.00234	0.00376	CcSEcCtD
Varenicline—Anaemia—Temozolomide—malignant glioma	0.00234	0.00374	CcSEcCtD
Varenicline—Agitation—Temozolomide—malignant glioma	0.00232	0.00372	CcSEcCtD
Varenicline—Angioedema—Temozolomide—malignant glioma	0.00231	0.0037	CcSEcCtD
Varenicline—Malaise—Temozolomide—malignant glioma	0.00228	0.00365	CcSEcCtD
Varenicline—Vertigo—Temozolomide—malignant glioma	0.00227	0.00364	CcSEcCtD
Varenicline—Convulsion—Carmustine—malignant glioma	0.00227	0.00363	CcSEcCtD
Varenicline—Hypertension—Carmustine—malignant glioma	0.00226	0.00362	CcSEcCtD
Varenicline—Palpitations—Temozolomide—malignant glioma	0.00223	0.00358	CcSEcCtD
Varenicline—Chest pain—Carmustine—malignant glioma	0.00223	0.00357	CcSEcCtD
Varenicline—Myalgia—Carmustine—malignant glioma	0.00223	0.00357	CcSEcCtD
Varenicline—Anxiety—Carmustine—malignant glioma	0.00222	0.00356	CcSEcCtD
Varenicline—Cough—Temozolomide—malignant glioma	0.00221	0.00354	CcSEcCtD
Varenicline—Convulsion—Temozolomide—malignant glioma	0.00219	0.00351	CcSEcCtD
Varenicline—Hypertension—Temozolomide—malignant glioma	0.00218	0.0035	CcSEcCtD
Varenicline—Myalgia—Temozolomide—malignant glioma	0.00215	0.00345	CcSEcCtD
Varenicline—Arthralgia—Temozolomide—malignant glioma	0.00215	0.00345	CcSEcCtD
Varenicline—Anxiety—Temozolomide—malignant glioma	0.00214	0.00344	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00214	0.00343	CcSEcCtD
Varenicline—Oedema—Carmustine—malignant glioma	0.00213	0.00342	CcSEcCtD
Varenicline—Discomfort—Temozolomide—malignant glioma	0.00213	0.00341	CcSEcCtD
Varenicline—Infection—Carmustine—malignant glioma	0.00212	0.0034	CcSEcCtD
Varenicline—Dry mouth—Temozolomide—malignant glioma	0.0021	0.00337	CcSEcCtD
Varenicline—Thrombocytopenia—Carmustine—malignant glioma	0.00209	0.00335	CcSEcCtD
Varenicline—Tachycardia—Carmustine—malignant glioma	0.00208	0.00334	CcSEcCtD
Varenicline—Oedema—Temozolomide—malignant glioma	0.00206	0.00331	CcSEcCtD
Varenicline—Infection—Temozolomide—malignant glioma	0.00205	0.00328	CcSEcCtD
Varenicline—Anorexia—Carmustine—malignant glioma	0.00203	0.00326	CcSEcCtD
Varenicline—Nervous system disorder—Temozolomide—malignant glioma	0.00202	0.00324	CcSEcCtD
Varenicline—Thrombocytopenia—Temozolomide—malignant glioma	0.00202	0.00324	CcSEcCtD
Varenicline—Skin disorder—Temozolomide—malignant glioma	0.002	0.00321	CcSEcCtD
Varenicline—Hypotension—Carmustine—malignant glioma	0.00199	0.0032	CcSEcCtD
Varenicline—Hyperhidrosis—Temozolomide—malignant glioma	0.00199	0.0032	CcSEcCtD
Varenicline—Anorexia—Temozolomide—malignant glioma	0.00197	0.00315	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00194	0.00312	CcSEcCtD
Varenicline—Insomnia—Carmustine—malignant glioma	0.00193	0.00309	CcSEcCtD
Varenicline—Dyspnoea—Carmustine—malignant glioma	0.0019	0.00305	CcSEcCtD
Varenicline—Somnolence—Carmustine—malignant glioma	0.0019	0.00304	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00188	0.00301	CcSEcCtD
Varenicline—Insomnia—Temozolomide—malignant glioma	0.00187	0.00299	CcSEcCtD
Varenicline—Decreased appetite—Carmustine—malignant glioma	0.00186	0.00297	CcSEcCtD
Varenicline—Gastrointestinal disorder—Carmustine—malignant glioma	0.00184	0.00295	CcSEcCtD
Varenicline—Dyspnoea—Temozolomide—malignant glioma	0.00184	0.00295	CcSEcCtD
Varenicline—Somnolence—Temozolomide—malignant glioma	0.00183	0.00294	CcSEcCtD
Varenicline—Pain—Carmustine—malignant glioma	0.00183	0.00293	CcSEcCtD
Varenicline—Constipation—Carmustine—malignant glioma	0.00183	0.00293	CcSEcCtD
Varenicline—Dyspepsia—Temozolomide—malignant glioma	0.00182	0.00291	CcSEcCtD
Varenicline—Decreased appetite—Temozolomide—malignant glioma	0.00179	0.00287	CcSEcCtD
Varenicline—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00178	0.00285	CcSEcCtD
Varenicline—Fatigue—Temozolomide—malignant glioma	0.00178	0.00285	CcSEcCtD
Varenicline—Pain—Temozolomide—malignant glioma	0.00176	0.00283	CcSEcCtD
Varenicline—Constipation—Temozolomide—malignant glioma	0.00176	0.00283	CcSEcCtD
Varenicline—Feeling abnormal—Carmustine—malignant glioma	0.00176	0.00282	CcSEcCtD
Varenicline—Gastrointestinal pain—Carmustine—malignant glioma	0.00175	0.0028	CcSEcCtD
Varenicline—Feeling abnormal—Temozolomide—malignant glioma	0.0017	0.00272	CcSEcCtD
Varenicline—Abdominal pain—Carmustine—malignant glioma	0.00169	0.0027	CcSEcCtD
Varenicline—Body temperature increased—Carmustine—malignant glioma	0.00169	0.0027	CcSEcCtD
Varenicline—Gastrointestinal pain—Temozolomide—malignant glioma	0.00169	0.0027	CcSEcCtD
Varenicline—Urticaria—Temozolomide—malignant glioma	0.00164	0.00263	CcSEcCtD
Varenicline—Abdominal pain—Temozolomide—malignant glioma	0.00163	0.00261	CcSEcCtD
Varenicline—Body temperature increased—Temozolomide—malignant glioma	0.00163	0.00261	CcSEcCtD
Varenicline—Hypersensitivity—Carmustine—malignant glioma	0.00157	0.00252	CcSEcCtD
Varenicline—Asthenia—Carmustine—malignant glioma	0.00153	0.00245	CcSEcCtD
Varenicline—Hypersensitivity—Temozolomide—malignant glioma	0.00152	0.00244	CcSEcCtD
Varenicline—Asthenia—Temozolomide—malignant glioma	0.00148	0.00237	CcSEcCtD
Varenicline—Diarrhoea—Carmustine—malignant glioma	0.00146	0.00234	CcSEcCtD
Varenicline—Pruritus—Temozolomide—malignant glioma	0.00146	0.00234	CcSEcCtD
Varenicline—Dizziness—Carmustine—malignant glioma	0.00141	0.00226	CcSEcCtD
Varenicline—Diarrhoea—Temozolomide—malignant glioma	0.00141	0.00226	CcSEcCtD
Varenicline—Dizziness—Temozolomide—malignant glioma	0.00136	0.00219	CcSEcCtD
Varenicline—Vomiting—Carmustine—malignant glioma	0.00136	0.00218	CcSEcCtD
Varenicline—Rash—Carmustine—malignant glioma	0.00135	0.00216	CcSEcCtD
Varenicline—Dermatitis—Carmustine—malignant glioma	0.00134	0.00216	CcSEcCtD
Varenicline—Headache—Carmustine—malignant glioma	0.00134	0.00214	CcSEcCtD
Varenicline—Vomiting—Temozolomide—malignant glioma	0.00131	0.0021	CcSEcCtD
Varenicline—Rash—Temozolomide—malignant glioma	0.0013	0.00208	CcSEcCtD
Varenicline—Dermatitis—Temozolomide—malignant glioma	0.0013	0.00208	CcSEcCtD
Varenicline—Headache—Temozolomide—malignant glioma	0.00129	0.00207	CcSEcCtD
Varenicline—Nausea—Carmustine—malignant glioma	0.00127	0.00203	CcSEcCtD
Varenicline—Nausea—Temozolomide—malignant glioma	0.00123	0.00196	CcSEcCtD
